Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.

Bizzarri, F; Scolletta, S; Tucci, E; Lucidi, M; Davoli, G; Toscano, T; Neri, E; Muzzi, L; Frati, G

Bizzarri, F; Scolletta, S; Tucci, E; Lucidi, M; Davoli, G; Toscano, T; Neri, E; Muzzi, L; Frati, G.

Affiliation

Bizzarri F; Instituto di Chirurgia Toracica, Cardiovascolare e Tecnologie Biomediche, Università degli Studi de Siena, Siena, Italy. bizzarri@unisi.it

J Thorac Cardiovasc Surg ; 122(6): 1181-5, 2001 Dec.

Article in En | MEDLINE | ID: mdl-11726894

Subject(s)

Coronary Artery Bypass; Platelet Aggregation Inhibitors/therapeutic use; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Postoperative Hemorrhage/epidemiology; Tyrosine/analogs & derivatives; Tyrosine/therapeutic use; Blood Transfusion/statistics & numerical data; Case-Control Studies; Emergencies; Female; Heparin/therapeutic use; Humans; Incidence; Male; Middle Aged; Postoperative Complications/epidemiology; Time Factors; Tirofiban

Search on Google

XML

PubMed Links

Collection: 01-internacional Topics: Promover_ampliacao_atencao_especializada Database: MEDLINE Main subject: Tyrosine / Platelet Aggregation Inhibitors / Coronary Artery Bypass / Postoperative Hemorrhage / Platelet Glycoprotein GPIIb-IIIa Complex Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Thorac Cardiovasc Surg Year: 2001 Document type: Article

Search on Google

XML

PubMed Links